Stock Analysis Call: Medical Supplies and CRISPR Technology Insights

This chapter features a lively call-in segment where listeners share their thoughts on various stocks, including a medical supplies company and Dexcom, following a disappointing report. The hosts also explore the potential of CRISPR technology, highlighting its promises and associated risks.